Technology Transfer
The Walter and Eliza Hall Institute’s dedicated basic and clinical scientists are driving innovative programs aimed at developing new approaches to the prevention and treatment of:
- Cancer – particularly leukemia, lymphoma and breast cancer
- Immunity – immune regulation, immunotherapy, vaccines
- Autoimmunity – diabetes, rheumatoid arthritis, coeliac disease
- Infectious diseases – malaria, chronic infectious diseases
The Institute is committed to translational medicine to ensure patient benefits It has a strong track record of successful collaborative development projects with some of the most respected names from both the private and public sectors.
Technology Transfer Collaborations
WEHI’s discovery pipeline is fed by more than 250 projects. A new patent application is filed every three weeks and the Institute’s intellectual property is the subject of more than 40 clinical trials currently being conducted worldwide.
The success of the Institute is evidenced through the creation of four biotechnology companies headquartered in Melbourne. For more information click here.
Team
Julian Clark – Head, Business Development
Carmela Monger – Intellectual Property and Contracts Manager
Tricia Diggle - Business Development Associate
James Dromey – Business Development Manager
Contact us
Business Development Office
The Walter and Eliza Hall Institute of Medical Research
1G Royal Parade
Parkville Vic 3052
Australia
Ph: +61 3 9345 2555
Fax: +61 3 9347 0852
Email: .(JavaScript must be enabled to view this email address)